title: Fungal vulvovaginitis.
abstract: Fungal vulvovaginitis remains one of the most frequent conditions affecting the lower genital tract. Recent advances in the understanding of the pathophysiology of the condition have improved our ability to treat recurrent or persistent cases. More clinical data have become available on the optimal duration of treatment with some of the newer antifungal agents.
authors.affiliation: Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030.
authors.forename: M L
authors.initials: ML
authors.lastname: Maccato
authors.forename: R H
authors.initials: RH
authors.lastname: Kaufman
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D015984:Causality; D003267:Contraception / Q000009:adverse effects; D048909:Diabetes Complications; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D014626:Vaginal Smears / Q000592:standards
chemical_list: D000935:Antifungal Agents